Zealand Pharma A/S financials at a glance

The revenue of Zealand Pharma A/S is reported as 0.34279 billion Kroner in the fiscal year 2023. The earnings were -12.44 Kroner per share in 2023, which was 39.29 higher than 2022. And about -0.43691 billion Kroner are reported as free cash flow in the financials of Zealand Pharma A/S 2023. No dividends were paid to the shareholders of the Zealand Pharma A/S stock CPSE:ZEAL in the financial year 2023.